InsidersTradesSigma
Follow the 티앤알바이오팹 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 티앤알바이오팹 has logged 11 insider filings. Market capitalisation: €115.3bn. The latest transaction was filed on 14 July 2026 (Other). Among the most active insiders: 윤원수. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
티앤알바이오팹是一家在XKRX市场上市的健康和制药领域的公司。它专注于开发用于再生医学的生物打印技术和解决方案。